W. Lichtenegger

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Brigitte Rack, Christian Schindlbeck, Julia Jückstöck et al. · JNCI Journal of the National Cancer Institute · 2014 · 606 citations · Full text

Medicine, Cancer Biology, Oncology +17

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Angela Reles, Wen H. Wen, Annette Schmider et al. · PubMed · 2001 · 284 citations

Medicine, Molecular Biology, Oncology +17

The importance of parametrial lymph nodes in the treatment of cervical cancer

F. Girardi, W. Lichtenegger, Karl Tamussino et al. · Gynecologic Oncology · 1989 · 143 citations

Medicine, Gynecology, Oncology +14

Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

Jalid Sehouli, Dirk Stengel, Guelten Oskay-Oezcelik et al. · Journal of Clinical Oncology · 2008 · 136 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells

Pengming Sun, Jalid Sehouli, Carsten Denkert et al. · Journal of Molecular Medicine · 2005 · 134 citations

Medicine, Cancer Biology, Oncology +17